Our laboratory focuses on identifying biomarkers for early diagnosis, monitoring the progression of cancer, screening, and personalized anti-cancer therapy (to achieve the general objectives of translational medicine in oncology).
It is equipped for Sanger sequencing experiments allowing for the identification of SNPs involved in different pathologies, as well as equipment for high-throughput next generation sequencing, such as The PGM Ion Torrent Sequencing, a reliable sequencing platform that combines simple sample preparation and data analysis solutions with scalable chip output, for ultimate project flexibility.
Furthermore, the NextSeq Series delivers the power of high-throughput sequencing with the speed, simplicity, and affordability of a desktop NGS (next-generation sequencing) system. The fast, integrated, sample-to-results workflow enables many sequencing applications—including transcriptomes, exomes, and targeted panels—in a single run.
With this systems, we can perform a variety of targeted gene sequencing applications, such as variant detection in cancer and genetic disorders.
Infrastructure